GLOW GHK-Cu (50mg) / BPC-157 (10mg) / TB500 (10mg) 
Tesamorelin (10mg) 
KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) 
Ipamorelin (10mg) 
Melanotan 2 (10mg) 
Cagrilintide (2.5mg) / GLP-1 S (2.5mg)
Price range: $100.00 through $150.00
Description
A two-component co-formulation of Cagrilintide and a GLP-1–class peptide supplied for controlled research environments. Suitable for studies exploring amylin-receptor–related and GLP-1–receptor signaling pathways in model systems.
Composition
• Cagrilintide
• GLP-1 S
• Fill Volume: 2 mL vial
• Appearance: Lyophilized powder in a sealed research vial
Research Focus (non-clinical)
• Combined pathway evaluation of amylin-receptor–related and GLP-1–receptor mechanisms in in-vitro or ex-vivo models
• Assay development, including chromatographic separation of two co-formulated peptides and blend ratio characterization
• Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions
• Method documentation for HPLC/LC-MS identity and purity assessments
For qualified research professionals and institutional laboratories. Not for human use.
Documentation & Quality Assurance
Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.
Important Notice
This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.
Quality & Manufacturing
All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.
We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.
All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.
Additional information
| Weight | 0.2 lbs |
|---|---|
| Dosage | (2.5mg) / (2.5mg), (5mg) / (5mg) |
Storage Instructions
All our research peptides are manufactured using a lyophilization (freeze-drying) process. This method is designed to maintain product integrity and allows vials to remain stable during shipping for approximately 3–4 months.
Once a vial is reconstituted with bacteriostatic water, it should be stored in the refrigerator to help maintain stability. Under these conditions, reconstituted material is generally considered stable for up to 30 days.
Lyophilization is a dehydration technique in which compounds are frozen and then exposed to low pressure. This causes the water in the vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure. This powder can be kept at room temperature until reconstitution.
Upon receipt, products should be stored away from heat and light. For short-term use, refrigeration at approximately 4°C (39°F) is suitable. For long-term storage (several months to years), vials may be placed in a freezer at approximately -80°C (-112°F). Freezing is the preferred method for preserving product stability over extended periods.
⚠️ Important Notice: These products are intended for research use only. Not for human consumption.
Certificate of Analysis
Every batch undergoes rigorous third-party laboratory testing to verify identity, purity (≥98%), and quality before release.
Research Use Only
These studies reference research-grade peptides for laboratory and scientific investigation only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Published Scientific Research
Peer-reviewed laboratory research investigating glp-1 receptor agonists from leading scientific databases
GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder.
GLP-1 receptor agonists are therefore approved for treating type 2 diabetes and obesity. However, more recent research has demonstrated that GLP-1 acts within the brain to modulate reward responses, thereby highlighting GLP-1 as a potential target for addiction.
View Full StudyIncretin hormones and type 2 diabetes.
This appears to be because of a reduced ability of GIP to stimulate insulin secretion, related either to an overall impairment of beta cell function or to specific defects in the GIP signalling pathway. This has led to the development of incretin-based glucose-lowering medications (selective GLP-1 receptor agonists or, more recently, co-agonists, e.g.
View Full StudyGLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons.
Polycystic ovary syndrome (PCOS) is a disorder that involves several organ systems and cellular pathways. This review analyzes the current evidence for GLP-1R agonists, focusing on their effects on ovarian morphology, menstrual dysfunction and fertility outcomes.
View Full StudyGLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
BACKGROUND: GLP-1 receptor agonists (GLP-1 RAs) with exenatide b.i.d. SCOPE OF REVIEW: To summarize current knowledge about GLP-1 receptor agonist.
View Full StudyBoosting GLP-1 by Natural Products.
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newly developed class of antidiabetic drugs that have potent hypoglycemic effects via several molecular pathways. In addition to synthetic GLP-1 receptor agonists, some evidence suggests that natural products may have modulatory effects on GLP-1 expression and secretion.
View Full StudyThe evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have their main physiological role in augmenting insulin secretion after their nutrient-induced secretion from the gut. GIP and GLP-1 have additive effects on insulin secretion.
View Full StudyRelated products
-
Sale!
Wolverine Blend – BPC-157 (5mg) / TB500 (5mg) (Globally Sourced)
Price range: $100.00 through $150.00Select options This product has multiple variants. The options may be chosen on the product page -
Epitalon
Price range: $100.00 through $150.00Select options This product has multiple variants. The options may be chosen on the product page -
